Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 20, 2025

October 20, 2025

Onco360® Has Been Selected as a Specialty Pharmacy Partner for PHYRAGO™ (dasatinib)

GlobeNewswire

October 20, 2025

Lirum Therapeutics Announces FDA “Study May Proceed” Letter Enabling Inclusion of LX-101 in the RAPID Platform Clinical Trial for Ewing Sarcoma and Desmoplastic Small Round Cell Tumor

GlobeNewswire

October 20, 2025

Health Catalyst to Announce Third Quarter 2025 Operating Results and Host Conference Call on Monday, November 10, 2025

GlobeNewswire

October 20, 2025

BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase

GlobeNewswire

October 20, 2025

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder

GlobeNewswire

October 20, 2025

BrightSpring Health Services, Inc. Reports Preliminary Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

GlobeNewswire

October 20, 2025

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

GlobeNewswire

October 20, 2025

Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union

GlobeNewswire

October 20, 2025

CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer

GlobeNewswire

October 20, 2025

Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares in the Public Offering

GlobeNewswire

October 20, 2025

Pacira BioSciences to Present 3-Year Data Demonstrating Sustained Pain and Function Improvements in Knee Osteoarthritis with Investigational PCRX-201 Gene Therapy

GlobeNewswire

October 20, 2025

Anresco Laboratories and NJ Labs Unite to Form Nationwide Testing Network Built on Trusted, Proven Expertise

GlobeNewswire

October 20, 2025

Global Abdominal Aortic Aneurysm Repair Devices Market to Increase at a Steady Growth Rate of ~6% by 2032 | DelveInsight

GlobeNewswire

October 20, 2025

Noom Launches AI Face Scan and AI Future Me to Bring Preventive Health Insights to Everyone

GlobeNewswire

October 20, 2025

ThrIVe Health Announces Patient Education Seminar Featuring Leading Thyroid Eye Disease Specialist Dr. Raymond Douglas

GlobeNewswire

October 20, 2025

IMPALA Appoints Ann Marie Dunne as New Chair, Succeeding Jonathan Taylor

GlobeNewswire

October 20, 2025

True Diagnostics Awarded BARDA RRPV Project to Advance Rapid Biothreat Test

GlobeNewswire

October 20, 2025

KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery

GlobeNewswire

October 20, 2025

Spark Biomedical Awarded an NIH Grant to Study the Treatment Effects of tAN® for Alcohol Withdrawal Symptoms

GlobeNewswire

October 20, 2025

KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery

GlobeNewswire